Eileen M McMahon
Global Guide 2024
Band 1 : Intellectual Property
Email address
[email protected]Contact number
+1 (416) 624-2410Share profile
Band 1
About
Provided by Eileen M McMahon
Practice Areas
Eileen’s market-leading experience, practical advice and industry insight in intellectual property and regulatory law make her a go-to advisor for clients in Canada and the United States.
Chair of Torys’ Intellectual Property and Food and Drug Regulatory practices, Eileen is one of a handful of Canadian lawyers who advise on regulatory clearance and intellectual property protection of products. Across sectors—including life sciences, agribusiness, regenerative medicine and stem cells, cannabis and more—Eileen helps clients identify IP and regulatory assets, obtain and maintain market exclusivity, exploit IP assets and enforce their IP rights.
Eileen is a registered patent and trademark agent in the United States and Canada and is adroit at navigating the issues at play in cross-border matters. She is also a Certified Licensing Professional of the Licensing Executive Society (LES) (2011-2014), United States and Canada. This certification is issued only to persons who have met the requirements for licensing professionals, established by CLP, Inc., under the guidance of the LES. Fewer than 1% of all attorneys have this certification, making Eileen a specialized resource for clients.
Articles, highlights and press releases
3 items provided by Torys LLP
Emerging Companies in Canada: Data and Digital Technology and Life Sciences
The growth of Canada’s emerging company and tech sector has been on a path of acceleration. We are also seeing increased foreign investment into the industry, particularly from America. The tech sector’s presence is being felt nationwide. Here we discuss key growth areas to watch moving forwards.
Rewiring the supply chain: how the pandemic is shaping government procurement
COVID-19 has long-term implications for how governments think about procurement. Obtaining vaccines & critical supplies was no easy feat during the pandemic. This article examines domestic production, foreign procurement and how the global supply chain is shaping public policy goals and objectives.
Torys Business Brief: A turning point for Canada’s life sciences
What lessons can be learned from the pandemic for the life sciences industry? Hear from Eileen McMahon and Cheryl Reicin and researcher Dr. Shaf Keshavjee
Emerging Companies in Canada: Data and Digital Technology and Life Sciences
The growth of Canada’s emerging company and tech sector has been on a path of acceleration. We are also seeing increased foreign investment into the industry, particularly from America. The tech sector’s presence is being felt nationwide. Here we discuss key growth areas to watch moving forwards.
Rewiring the supply chain: how the pandemic is shaping government procurement
COVID-19 has long-term implications for how governments think about procurement. Obtaining vaccines & critical supplies was no easy feat during the pandemic. This article examines domestic production, foreign procurement and how the global supply chain is shaping public policy goals and objectives.
Torys Business Brief: A turning point for Canada’s life sciences
What lessons can be learned from the pandemic for the life sciences industry? Hear from Eileen McMahon and Cheryl Reicin and researcher Dr. Shaf Keshavjee